CTCBIO Inc. (KOSDAQ:060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,000.00
+130.00 (3.36%)
At close: May 14, 2026
Market Cap92.53B -45.5%
Revenue (ttm)123.77B +3.2%
Net Income3.24B
EPS136.00
Shares Out23.91M
PE Ratio28.22
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume221,245
Average Volume186,671
Open3,750.00
Previous Close3,870.00
Day's Range3,750.00 - 4,090.00
52-Week Range3,480.00 - 7,680.00
Beta0.01
RSI50.65
Earnings DateMay 19, 2026

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

Financial Statements